| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
30 |
| Equity
Latest Equity |
16.6 |
| Face Value
Latest Face Value |
2 |
| Reserves
Total Reserve |
58.88 |
| Dividend
Full Year Dividend % |
0 |
| Sales Turnover
Full Year Net Sales |
206.38 |
| Net Profit
Full Year Net Profit |
13.12 |
| Full Year CPS
Full Year Cash Per Share |
2 |
| Earning Per Share
Full Year Earning Per Share |
1.6 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Mar 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
56.81 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
9.1 |
| Networth
Full Year Return on Networth |
17.57 |
| Price/Book Value
Price to Book value |
4.175824 |
| Yearly PE ratio
Full Year Price to Earning per share |
24 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
19.5 |
| Bse value
BSE Value in lakhs |
0.19 |
| Nse value
NSE Value in lakhs |
9.05 |
| High
52 week high |
57 |
| Low
52 week low |
31 |
| Price
NSE Current market price |
38 |
| CPM
Current market price |
38 |
| Market cap
BSE / NSE Market Cap |
317 |
| Net profit
Latest Quarter Net Profit |
5.86 |
| Net profit variance
Latest Quarter Net Profit variance |
35 |
| Result year
Trailing latest month |
Mar 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
141.24 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
12.6 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
8.92 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
21.15 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
10.25 |
| TTM NP
Trailing Twelve 12 month Net Profit |
7.68 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
29.94 |
| TTM EPS
Trailing Twelve 12 month EPS |
1.58 |
| TTM PE
Trailing Twelve 12 month PE |
24.18 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
2.96 |
| Equity
Latest Equity |
16.6 |
| LTP
Latest Price (BSE/NSE) |
38 |
| Gross block
Latest Gross Block |
44.09 |
| Loans
Total loans |
1.95 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
8.3 |
| Year GPM
Full Year Gross Profit Margin |
10.3 |
| Quarter OPM
Latest quater Operation Profit Margin |
12.6 |
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 31 | 39 | 39 | 41 | 38 | 53 | 59 | 57 |
| YOY Sales Growth % | -2% | -7% | 33% | -0% | 24% | 34% | 49% | 38% |
| Gross Sales | 31 | 39 | 39 | 41 | 38 | 53 | 59 | 57 |
| + Expenses | 28 | 37 | 36 | 35 | 35 | 50 | 54 | 50 |
| Material Cost % | 77% | 70% | 85% | 78% | 80% | 90% | 52% | 73% |
| Raw Material Cost | 23 | 28 | 31 | 29 | 29 | 43 | 36 | 40 |
| Change in Inventory | 1 | -1 | 3 | 3 | 2 | 4 | -6 | 1 |
| Manufacturing Cost % | 15% | 13% | 15% | 14% | 17% | 15% | 14% | 15% |
| Employee Cost % | 5% | 4% | 5% | 4% | 4% | 3% | 4% | 3% |
| Other Cost % | -5% | 7% | -12% | -11% | -9% | -13% | 23% | -4% |
| Raw Materials % | 73% | 72% | 78% | 71% | 75% | 82% | 62% | 71% |
| Purchase of Finished Goods % | 2% | 2% | 1% | 1% | 2% | 2% | 4% | 1% |
| Stock Adjustments % | -3% | 3% | -7% | -6% | -5% | -8% | 10% | -2% |
| Other Manufacturing Expenses % | 15% | 13% | 15% | 14% | 17% | 15% | 14% | 15% |
| Operating Profit | 3 | 2 | 3 | 7 | 3 | 3 | 4 | 7 |
| OPM % | 9% | 6% | 8% | 16% | 7% | 5% | 7% | 13% |
| + Other Income | 0 | 1 | 1 | 0 | 1 | 2 | 1 | 3 |
| Miscellaneous Income | 0 | 1 | 1 | 0 | 1 | 2 | 1 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 2 | 4 | 6 | 2 | 3 | 4 | 8 |
| + Tax % | 27% | 27% | 25% | 24% | 26% | 26% | 25% | 30% |
| Current Tax | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 3 |
| Deferred Tax | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | 2 | 3 | 4 | 2 | 3 | 3 | 6 |
| EPS in Rs |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Sales | 67 | 57 | 62 | 98 | 89 | 122 | 121 | 140 | 145 | 151 |
| Sales Growth % | -14% | 8% | 58% | -9% | 38% | -1% | 16% | 3% | 4% | |
| Gross Sales | 121 | 140 | 145 | 151 | ||||||
| Excise Duty | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Expenses | 64 | 50 | 62 | 97 | 93 | 114 | 114 | 131 | 132 | 136 |
| Material Cost % | 79% | 68% | 70% | 81% | 76% | 75% | 72% | 75% | 76% | 72% |
| Raw Material Cost | 53 | 38 | 46 | 80 | 71 | 91 | 88 | 106 | 108 | 113 |
| Change in Inventory | 0 | 0 | -2 | -1 | -4 | 2 | 0 | -1 | 2 | -5 |
| Manufacturing Cost % | 0% | 4% | 7% | 5% | 7% | 6% | 7% | 6% | 6% | 7% |
| Employee Cost % | 6% | 8% | 6% | 3% | 4% | 4% | 4% | 4% | 4% | 4% |
| Other Cost % | 10% | 7% | 17% | 9% | 18% | 8% | 10% | 9% | 5% | 7% |
| Raw Materials % | 80% | 67% | 74% | 82% | 80% | 74% | 72% | 76% | 74% | 75% |
| Purchase of Finished Goods % | 2% | 4% | 1% | 1% | ||||||
| Stock Adjustments % | 1% | -1% | 4% | 1% | 4% | -1% | 0% | 1% | -1% | 3% |
| Power & Fuel % | 0% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 2% |
| Other Manufacturing Expenses % | 0% | 2% | 5% | 4% | 5% | 4% | 5% | 4% | 4% | 5% |
| Selling & Administration % | 9% | 7% | 8% | 6% | 9% | 9% | 9% | 8% | 4% | 7% |
| Miscellaneous Expenses % | 0% | 2% | 1% | 1% | 1% | 2% | 1% | 0% | 1% | -0% |
| Operating Profit | 3 | 7 | -1 | 1 | -4 | 8 | 7 | 10 | 13 | 15 |
| OPM % | 4% | 13% | -1% | 1% | -5% | 7% | 6% | 7% | 9% | 10% |
| + Other Income | 0 | 0 | 1 | 2 | 2 | 1 | 2 | 4 | 2 | 3 |
| Miscellaneous Income | 2 | 4 | 2 | 3 | ||||||
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| Profit before tax | 6 | 10 | 11 | 14 | ||||||
| + Tax % | 26% | 28% | 27% | 25% | ||||||
| Current Tax | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 |
| Deferred Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Net Profit | 5 | 7 | 8 | 10 | ||||||
| Profit Growth % | 54% | 14% | 22% | |||||||
| EPS in Rs |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 3 | 4 | 4 | 4 | 4 | 17 | 17 | 17 | 17 |
| Reserves | 13 | 13 | 23 | 24 | 26 | 28 | 20 | 27 | 36 | 46 |
| + Borrowings | 14 | 19 | 13 | 14 | 14 | 15 | 13 | 10 | 8 | 15 |
| Secured Borrowings | 8 | 10 | 11 | 11 | 13 | 13 | 10 | 8 | 6 | 13 |
| Unsecured Borrowings | 5 | 9 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 |
| + Other Liabilities | 17 | 13 | 20 | 35 | 32 | 28 | 28 | 34 | 36 | 43 |
| Current Liabilities | 17 | 13 | 20 | 34 | 32 | 28 | 28 | 34 | 36 | 43 |
| Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
| Other liability items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 46 | 48 | 59 | 76 | 75 | 76 | 77 | 87 | 96 | 120 |
| + Fixed Assets | 7 | 7 | 7 | 12 | 13 | 15 | 18 | 22 | 21 | 21 |
| Gross Block | 7 | 15 | 15 | 22 | 24 | 29 | 32 | 39 | 41 | 44 |
| Accumulated Depreciation | 0 | 8 | 9 | 10 | 12 | 14 | 14 | 17 | 20 | 23 |
| CWIP | 0 | 3 | 4 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 |
| + Other Assets | 38 | 39 | 48 | 63 | 60 | 59 | 59 | 64 | 73 | 97 |
| Inventories | 9 | 10 | 15 | 16 | 18 | 15 | 18 | 20 | 16 | 27 |
| Trade receivables | 20 | 18 | 17 | 29 | 24 | 27 | 30 | 36 | 50 | 57 |
| Cash Equivalents | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 0 | 1 |
| Loans n Advances | 7 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 6 | 11 |
| Other asset items | 1 | 0 | 2 | 4 | 4 | 2 | 2 | 1 | 1 | 1 |
| Total Assets | 46 | 48 | 59 | 76 | 75 | 76 | 77 | 87 | 96 | 120 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | -4 | -3 | 5 | 5 | 1 | -11 | 6 | 8 | 2 | 5 |
| Profit Before Tax & Extraordinary Items | 2 | 2 | 2 | 2 | 2 | 3 | 6 | 10 | 11 | 14 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| Interest (Net) | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit / Loss on Sale of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Provisions & Write-offs (Net) | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | -1 |
| Receivables | -12 | 2 | 1 | -12 | 5 | -27 | -4 | -6 | -14 | -7 |
| Inventories | -1 | -1 | -5 | -1 | -2 | -15 | -4 | -2 | 3 | -10 |
| Trade Payables | 3 | -3 | 6 | 15 | -6 | 25 | 2 | 4 | 1 | 3 |
| Loans & Advances | 1 | -2 | -4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Borrowing | 2 | -2 | 2 | 1 | -3 | 0 | 1 | -1 | -1 | 7 |
| Direct Taxes Paid | -1 | 0 | -1 | -1 | -1 | -1 | -2 | -3 | -3 | -4 |
| Extraordinary Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Cash from Investing Activity | 0 | -3 | -5 | -4 | -3 | -17 | -2 | -7 | -3 | -3 |
| Purchase of Fixed Assets | 0 | -1 | -2 | -3 | -2 | -17 | 0 | 0 | 0 | 0 |
| Sale of Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale of Investments | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital WIP | 0 | 0 | 0 | -1 | -1 | 0 | -6 | -7 | -2 | -3 |
| Investment Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Received | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | 0 | -2 | -2 | -1 | 0 | 0 | 1 | 0 | 0 | 0 |
| + Cash from Financing Activity | 2 | 6 | -1 | -1 | 3 | 18 | -6 | -2 | 0 | -1 |
| Proceeds from Issue of Shares | 0 | 0 | 9 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| Proceeds from Other Long-Term Borrowings | 4 | 0 | 0 | 0 | 4 | 5 | 0 | 0 | 0 | 0 |
| Proceeds from Short-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 |
| Proceeds from Deposits | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Financial Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Others | -1 | 7 | -9 | 0 | 0 | 0 | -5 | -1 | 0 | 0 |
| Net Cash Flow | -1 | 0 | -1 | 0 | 0 | -10 | -2 | 0 | -1 | 1 |